Myokine secretion in cultured human skeletal muscle cells by Stray, Katinka
Myokine secretion in cultured 
human skeletal muscle cells 
Katinka Stray 
 
Department of Nutrition  




The present work was conducted from August 2006 to May 2008 at the Department 
of Nutrition, University of Oslo in the laboratory of professor Christian A. Drevon. 
 
First of all I would  like to thank my supervisor Christian A. Drevon for his  
engagement during this year, and his ability to always, no matter how busy, have time 
to share.  
 
Special thanks to my co-supervisors Andreas Wensaas and Fred Haugen for help and 
most sympathetic support through the whole master project, and to Anne Randi Enget 
for technical support in the lab. 
 
Thanks to Terje Lund and Jens P Berg at Hormonlaboratoriet at Aker University 
Hospital for cooperation and performance of proteomics. 
 
Further, thanks to my love Chuck for being my inspiration all the way, and my 
children Oscar, Eliza and Savannah for keeping me sane during this time. And thanks 
to my brother Joachim, my sister-in-law Vibeke and my mother Kirsten for wise 
advices, numberless talks and for massive support. 
 
Finally, special thanks to Anette Skarpaas, my lab partner and close friend, for 
making this possible.  
 3
Abstract 
It is well established that exercise protect againsts chronic disorders such as 
cardiovascular diseases (CVD), type 2 diabetes (DM2), dementia and depression. It is 
unclear how contracting skeletal muscles mediate metabolic positive effects on 
health. One of the possible explanations for the health benefit of exercise can be that 
regular muscle contractions mediate important messengers; myokines. Experiments 
have shown an increased IL-6 concentration in plasma following skeletal muscle 
contraction. IL-6 is being released from skeletal muscle following a meal. This 
suggest that myokine release can also be modulated with diet.  
In the present study cultured human myotubes (an in vitro model for skeletal muscle) 
were incubated in serum-free medium with and without energy-carrying metabolites 
for different periods of time. The purpose was to investigate the release of peptides 
and proteins by cultured human myotubes and further study the effect of energy-
carrying metabolites on the release. The release of proteins was analyzed by the use 
of ELISAs and proteomic analysis performed on conditioned media from the cultured 
human myotubes. The inhibitor Brefeldin A was used to explore whether the release 
of proteins was due to secretion or leakage. The results show that cultured human 
myotubes release the proteins interleukin-6 (IL-6), interleukin-7 (IL-7), interleukin-8 
(IL-8) and interleukin-13 (IL-13), and that the release perhaps can be influenced by 
different energy-carrying metabolites. The mean concentration of the different 
proteins measured in the media was generally lower when the myotubes were 
incubated in media containing the inhibitor Brefeldin A (BFA), indicating that the 
release of proteins from myotubes is due to secretion. Our studies support the theory 
that myotubes release proteins with hormonal functions, and that the release might be 




BC   Bicinchoninic acid 
BSA   Bovine serum albumin 
CVD   Cardiovascular diseases 
DHA   Docosahexaenoic acid 
DM2   Diabetes Mellitus type 2 
DMEM  Dulbecco’s modified Eagle’s Medium 
DMSO  Dimethyl sulphoxide 
ELISA  Enzyme Linked Immunosorbent Assay 
EPA   Eicosapentaic acid 
ER   Endoplasmatic reticulum 
FCS   Foetal Calf Serum 
FFA   Free fatty acids 
GM-CSF  Granulocyte macrophage- colony stimulating factor 
IFN-γ   Interferron-γ 
IL-1β   Interleukin-1β 
IL-2   Interleukin-2 
IL-4   Interleukin-4 
IL-5   Interleukin-5 
IL-6   Interleukin-6 
IL-7   Interleukin-7 
IL-8   Interleukin-8 
IL-10   Interleukin-10 
IL-12   Interleukin-12 
IL-13   Interleukin-13 
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IL-15   Interleukin-15 
LDH   Lactate dehydrogenase 
MALDI-TOF MS Matrix-assisted laser desorption/ionization-time of flight mass 
spectrometer 
MQW   Milli-Q Water 
OA   Oleic acid 
PA   Palmitic acid 
SPDI   Secreted Protein Discovery Initiative 
TNF-α  Tumor necrosis factor-α 
2-D PAGE  Two-dimensional Polyacrylamid Gel Electorphoresis 
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1.1 Health effects of exercise 
It is well established that exercise protect againsts chronic disorders such as 
cardiovascular diseases (CVD), type 2 diabetes (DM2), dementia and depression [1]. 
Physical activity has been proven effective in the treatment of these and many other 
different medical disorders. Some of these beneficial effects are mediated through an 
improved lipid profile, elevated insulin sensitivity and lower blood pressure [2]. 
Striated skeletal muscle is one of the body’s largest tissues, ca 40 % of the body mass 
in a normal slim individ.  However, it is unclear how contracting skeletal muscles 
mediate metabolic positive effects on health. One of the possible explanations for the 
health benefit of exercise can be that regular muscle contractions mediate important 
messengers; myokines [3]. It might be that released myokines can explain how 
normal muscle activity can influence mood, physical performance and cognitive 
function [1]. 
1.2 Myokines 
In the last years we have seen accumulating evidence that skeletal muscle release 
hormone-like substances. Secreted proteins play an important regulatory role in 
intercellular communication. When the muscle tissue communicate with other tissues 
and organs, we believe that it does so by releasing myokines [4]. Myokines are signal 
peptides with potential hormonal effect, that are being released by muscle cells [5]. 
Different tissues throughout the body have been proven to communicate with each 
other via hormonal signals synthesized and secreted into the circulation as 
demonstrated for adipose tissue [6].  
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Illustration1. Muscle cells release myokines that affect other tissues throughout the body. 
1.3 Skeletal muscle 
Muscle is a very specialized tissue that has the ability to contract and conduct 
electrical impulses. Muscles are classified functionally as voluntary or involuntary, 
and structurally as striated or smooth muscle. A skeletal muscle is composed of 
bundles of muscle fibers that generally extend the entire length of the muscle. The 
cells are called fibers because of their threadlike shape [7].  
In the adult skeletal muscle there is a pool of undifferentiated  mononuclear cells, 
called satellite cells. They are quiescent in normal adult muscle and can be activated 
by stimuli such as myotrauma. Once activated, satellite cells divide to produce 
satellite cell-derived myoblasts that further proliferate, before differentiating and 
fusing to form multinucleated myotubes, which then mature into myofibers [8]. When 
the satellite cells are grown in culture they are seeded in a special medium, and the 





Illustration 2. Satellite cells occupy a sublaminar position in adult skeletal muscle. In the uninjured 
muscle fiber, the satellite cell is quiescent and rests in an indentation in the adult muscle fiber. The 
satellite cells can be distinguished from the myonuclei by a surrounding basal lamina and more 
abundant heterochromatin. When the fiber becomes injured, the satellite cells become activated and 
increase their cytoplasmic content. The cytoplasmic processes allow for chemotaxis of the satellite 
cell along the myofiber. Bar 5 1 mm. 
 
           
Picture 1 Human skeletal satellite cells. To the left; undifferentiated satellite cells. To the right; 
differentiated myotubes. Photo by Vigdis Aas. 
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1.4 Myokines are released from skeletal muscle cells 
Experiments have shown an increased IL-6 concentration in plasma following 
skeletal muscle contraction [3]. Physical activity is associated with a systemic 
cytokine response comparable with levels observed during severe infections, except 
for that the increase of Tumor necrosis factor-α (TNF- α) and Interleukin 1-β (IL-1β) 
is minimal if at all present after concentric exercise without muscle damage.  This 
indicates that in non-traumatic exercise models, the cytokine cascade differs 
markedly from the classical acute-phase response studied during infections [3]. 
Skeletal muscle accounts for the majority of insulin-stimulated glucose use and is 
therefore the major site of insulin resistance [9]. Insulin resistance is a major 
characteristic of type 2 diabetes mellitus and is also associated with obesity, 
hypertension and cardiovascular disease. Circulating IL-6, insulin and free fatty acid 
concentrations are associated with impaired insulin action in obese and type 2 
diabetic individuals [10]. IL-6 production is modulated by the carbohydrate 
availability in skeletal muscle, suggesting that IL-6 functions as an energy-sensor. 
The IL-6 response can be a signal that the muscle glycogen stores reach critically low 
levels. IL-6 is being released following exercise and it seems a paradox that working 
muscle should release a factor that inhibits insulin signaling when insulin action is 
increased in the immediate postexercise periode [4]. IL-6 induces strong anti-
inflammatory effects, inhibits low-grade TNF-α production and may inhibit TNF-α-
induced insulin resistance. IL-6 might thereby have an important role in mediating 
the beneficial effects of exercise [11]. 
Production of IL-6 in contracting human skeletal muscle cells can account for the 
exercise-induced increase in plasma IL-6 [12]. Muscle contractions induce IL-6 
mRNA-production in skeletal muscle in rats, showing that muscle tissue is the origin 
of IL-6 [13]. Further, it has been documented that the muscle cells are the cells 
responsible for the release of IL-6 [14-16].  
Plasma concentration of interleukin-8 (IL-8) increases as a response from eccentric 
exercise, whereas concentric exercise with moderate intensity does not increase the 
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plasma concentration. High local expression and small release suggests that it 
perform its effect locally. Because of this IL-8 is classified as potential muscle 
derived myokine [4].  IL-15 (Interleukin-15) is constitutively expressed and might 
play a role in adipose-muscle cross-talk, and is therefore classified as a potential 
muscle derived myokine [4]. 
1.5 Myokines and diet 
IL-6 is being released from skeletal muscle following a meal [17]. This combined 
with the fact that palmitate increase IL-6 from skeletal muscle cells in vitro [10] 
suggest that myokine release can also be modulated with diet.  
1.6 The skeletal muscle secretome 
Around 1000 new genes that probably encode secreted proteins are described by the  
Secreted Protein Discovery Initiative (SPDI). Bortoluzzi identified by computational 
approach 319 proteins putatively secreted by skeletal muscle during normal 
conditions. The skeletal muscle secretome can vary with different conditions, some 
proteins are secreted only during development or regeneration. The interleukin-6 (IL-
6) gene, for example, is quiet in resting muscle, but activated by physical activity [2]. 
1.7 Proteomics 
Proteomics is the study of proteins, their structure, expression, function and 
interactions with other molecules. The proteome includes all proteins produced by the 
human genome at any one time. The genome is the same in most cells, whereas the 
proteome varies with cell type. The environment and what is going on inside the cell 
e.g. cell division also influence the proteome. In our search for myokines we used 
different techniques considered essential for proteomics research like two-
dimensional polyacrylamide gel electrophoresis (2-D PAGE) and mass spectrometry 




1.8.1 Study release of peptides and proteins by human myotubes 
in culture 
The first object of this study was to investigate if we could detect proteins released 
from cultured human myotubes with our model.  
1.8.2 Study the effect of energy-carrying metabolites on the 
release of proteins from human myotubes in culture 
The second object was to incubate myotubes with energy-carrying nutrients and 
examine how this will influence the release of myokines. 
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2. Materials and methods 
2.1 Materials  
Dulbecco’s modified eagle medium with L-Glutamine (DMEM), 10 % foetal calf 
serum (FCS) and penicillin-streptomycin 5000IU/mL - 5mg/mL was obtained from 
Sigma Chem, St.Lois, MO, USA. Ultroser G was obtained from BioSepra, Ciphergen 
Biosystem Inc, Paris, France. Extracellular matrix gel (ECM), essentially fatty acid 
free bovine serum albumin, bovine serum albumin (used for protein standard) Sigma 
Chem. Co, palmitic acid (PA), oleic acid (OA), eicosapentaic acid (EPA),  DHA was 
obtained from Nu-Chek prep, Inc, Elysian, MN, USA. 14C labelled BSA was 
delivered by Perkin Elmer, Waltham, Massachusetts 02451 USA. Insulin Actrapid 
was obtained from Novo Nordisk, Bagsværd, Denmark. Trizol reagent was purchased 
from Invitrogen, Carlsbad, CA, USA. Bio-Rad protein assay dye reagent concentrate 
was obtained from Bio-Rad Laboratories, CA, USA. 12-well plates were obtained 
from Corning, NY, USA. Total protein was measured with Titertek Multiskan, 
Labsystems Oy, Helsinki, Finland. Cell Bind Flasks Corning, NY, USA. DMEM w/o 
glucose, phenol red, L-Glutamine, Sigma Chem. Co and IL-6 immunoassay, came 
from R&D Systems, MN, USA. Multiplex Immunoassay was from Lincoplex, St. 
Charles. Missouri, USA, and glucose was delivered by Sigma Chem. Co, the LDH-kit 
was delivered by Roche Diagnostics, Roche Applies Science, Mannheim, Germany, 
whereas RD 193058100 Human Myostatin ELISA came from BioVendor. For 
protein assay, the BC Assay protein kit was obtained from Uptima Interchim, 
Montluçon, France. 
2.2 Cell culture 
A cell bank of satellite cells was established from muscle biopsy samples taken from 
musculus vastus lateralis or m. obliqulus internus abdominis from healthy volunteers, 
aged 24.7 ± 0.7 years with body mass index 23.6 ± 1.1 kg/m2. The biopsies were 
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obtained with informed consent and approval by the National Committee for Research 
Ethics (Oslo, Norway). Muscle cell cultures free of fibroblasts were established by 
the method of Henry et al. with minor modifications. The cells were cultured in a 
humidified 5% CO2 atmosphere at 37°C, and medium was changed every 2–3 days. 
Medium 1 (M1) for seeding. 500 mL DMEM with low glucose (SIGMA, #D6046), 
50 mL FCS (Foetal Calf Serum (SIGMA, #F7524), 5 mL L-glutamine (SIGMA, 
#G7513, 100 mL), 5 mL Penicillin/Streptomycin (GIBCO BRL, #15140-114, 100 
mL) 
M2 for proliferation. 500 mL DMEM with low glucose (SIGMA, #D6046), 10 mL 
FCS (Foetal Calf Serum (SIGMA, #F7524), 10 mL Ultroser G, 5 mL L-glutamine 
(SIGMA, #G7513, 100 mL, 5 mL Penicillin/Streptomycin (GIBCO BRL, #15140-
114, 100 mL) 
M3 for differentiation. 500 mL DMEM with low glucose (SIGMA, #D6046), 10 mL 
FCS (Foetal Calf Serum (SIGMA, #F7524), 5 mL L-glutamine (SIGMA, #G7513, 
100 mL), 5 mL Penicillin/Streptomycin (GIBCO BRL, #15140-114, 100 mL, 25 
pmol Insulin (⇒21 μl of 1000 x diluted Insulin Actrapid®, Novo Nordisk, 0,6 mM) 
Ultroser-G (Bio Serpa, #P/N 15950-017) should be re-constituted by adding of 20 mL 
MQW to the container. Wait for 15 minutes, and transfer 10 mL to M2-medium. The 
rest (10 mL) is frozen (-20 °C) for further use. 
2.3 Methods  
2.3.1 Seeding satellite cells 
Primary skeletal muscle cells were grown from satellite cells.  1 vial containing the 
satellite cells (approximately 1.5 million cells) was picked up from the tank 
containing liquid nitrogen. The suspension was thawed in 37 ˚ C until only a tiny 
piece of ice was left. In a LAF bench the cell suspension was added to a 50 mL tube 
containing 9 mL or 15 mL prewarmed M1 or 15 mL prewarmed SKBM depending on 
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the format used (12 well plate or 75 cm2 flask). This was performed to avoid the cells 
to be exposed to the high concentration of DMSO which is poisonous for the cells 
when they are not frozen. The cell suspension was well mixed with M1 by a pipette. 
The cells were seeded with 750 uL medium in each well in the 12 well plate and 15 
mL in the 75 cm2 flask and incubated in 37˚C and 5% CO2 over night. The day after 
the medium was changed from M1 to 1 mL M2 for the plates, SKGM (SKBM + 
bullet kit without the insulin + 2,5 mL Fungibact + 5 mL Glutamine) + 2 % FCS for 
the flasks. Bullet kit was added to increase the proliferation but inhibit differentiation. 
M2 and SKGM was changed every second or third day. When the cells had reached 
80% confluence the medium was changed to either 1 mL M3 for the 12 well plate or 
15 mL for the flask. When changing medium to M3 at this point the cells 
differentiated into multinucleated myotubes. The M3-medium was changed every 
second or third day. The experiments were performed either before M3-medium were 
given (undifferentiated cells) or after 2 or 5 days. Different substances were added to 
either M3 or DMEM according to the experiment performed. The cells were visually 
inspected under microscope during growth, differentiation and experiments. 
Trypsination was performed on the flasks to loosen the cells from the bottom for 
making possible the moving of the cells to bigger flasks. Medium was removed by 
vacuum. The cells were washed by adding and removing 5 mL roomtempered PBS in 
each flask to avoid trypsin from inactivation. 5 mL trypsin were added to each flask 
and incubated for 5 min by 37° C in 5% CO2. The cells were checked in the 
microscope to verify that they had loosened from the bottom. The suspension was 
transferred to a vial. The flasks were added 5 mL DMEM with 2 % FCS to inactivate 
trypsin, this was also transferred to the same vial. The vial was centrifuged 3 minutes 
on 1500 rpm to get rid of trypsin and FCS. The supernatant was removed. The pellet 
was resuspended in 3 mL SKGM in the same vial. The new flasks were added 20 mL 
SKGM. The cells were shared between the new flasks 
2.3.2 Monitoring cell damage by LDH activity 
The myotubes were exposed to various potentially harmful substances in the different 
experiments. To monitor their well being we used Cytotoxicity Detection Kit that 
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measures how much of the intracellular enzyme lactate dehydrogenase (LDH) is 
leaking through the membrane. This can be used as a general marker on whether the 
cells are intact or not.  Conditioned media was centrifuged on 3000 rpm for 5 min (on 
the day of harvesting to avoid dead cells from leaking LDH), 25 uL supernatant was 
transferred from each vial to a flat bottom 96-well plate. To each well 25 uL milliQ 
water and 50 uL LDH reagents were added. The muscle cells were lysated in 100-
1000 uL 2% Triton X-100, 20 uL from the lysate were transferred to a flat bottom 96-
well plate. To each well 30 uL MQW and 50 uL LDH reagents were added. The 96-
well plates were incubated in 37˚C for 15 minutes, wrapped in foil. The absorbance 
was measured by a spectrophotometer (Titertec) on 492 nm. Blank background 
samples consisting of either only DMEM or lysis-solution were measured in parallel 
and the value were subtracted from the respective values from the samples 
2.3.3 Lysing muscle cells with Triton X-100 
Lysing the cells was done to obtain 100 % LDH-leakage. 0,5 mL 2 % Triton X-100 in 
MQW was added to each well. The cells were incubated at 37 C in 5 % CO2 for 5 
min, and lysate collected in vials. 20 uL lysate from each vial was transferred to 96-
well plates. The absorbance was measured by a spectrophotometer (Titertec) on 492 
nm. 
2.3.4 Protein quantification of the lysates 
BC (bicinchoninic acid) Assay and Bio-Rad Assay were used to determine the 
amount of protein in samples. The BC-reagent reduces Cu2+ in alkaline solutions to 
Cu+ and two molecules of BCA interact with each molecule of Cu+ forming a water 
soluble red complex. The Bio-Rad Protein Assay is a dye-binding assay in which a 
differential colour change occurs in response to the concentration of protein. 
Coomassie blue dye binds to primarily basic amino acid residues, especially arginine. 
Cell lysates were homogenized and 25 uL of each homogenate was transferred to 
separate wells on a flat bottom 96-wells plate. Protein standards made from BSA by 
serial dilution were likewise added to separate wells. Each well was added 200 uL 
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reconstituted coomassie reagent or BC-reagent, and the plate was then incubated at 
room temperature (5 or 30 min for Coomassie and BC-reagent, respectively). The 
absorbance values were determined by a spectrophotometer (Titertec) at either 590 
nm (Coomassie) or 490 nm (BC). Sample protein concentrations were determined by 
plotting the absorbance values into the linear function obtained from the protein 
standards. 
2.3.5 IL-6 measurements 
ELISA is a sensitive immunoassay that uses an enzyme linked to an antibody as a 
marker for the detection of a specific protein. This assay employs the quantitative 
sandwich enzyme immunoassay technique. A monoclonal antibody specific for IL-6 
has been pre-coated onto a microplate. Standards and samples were pipetted into the 
wells, and any IL-6 present was bound by the immobilized antibody. The samples 
were compared against the standards curve to determine the amount of IL-6 present. 
Results were expressed in pg/mL. The lower detection limit was 0.07 pg/mL. 100 uL 
of Assay Diluent RD1W was added to each well. 100 uL of Standard, sample, or 
control was added to each well. The plate was incubated for 2 hours at room 
temperature. Each well was aspirated and washed, the process was repeated three 
times for a total of four washes. Each well was washed by filling Wash Buffer (400 
uL) using a manifold dispenser. After the last wash, any remaining Wash Buffer was 
removed by aspirating or decanting. 200 uL of IL-6 Conjugate was added to each 
well. The plate was incubated for 2 hours at room temperature. The aspiration/wash 
was repeated as in step 5. 200 uL of Substrate Solution was added to each well. The 
plate was incubated for 20 minutes at room temperature protected from light. 50 uL 
of Stop Solution was added to each well. Determine the optical density of each well 
within 30 minutes, using a microplate reader set to 450 nm.  
2.3.6 Myostatin measurements 
In the BioVendor Human Myostatin ELISA (Prodomain Specific), Calibrators, 
Quality Controls (QCs) and samples of sera or plasma are incubated in microtitration 
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wells coated with monoclonal anti-human myostatin prodomain antibody. After one 
hour incubation and washing, biotin labelled polyclonal anti-human myostatin 
prodomain antibody is added and incubated with captured myostatin prodomain or 
prodomain complex. 100 μl of diluted Calibrators (0.1-10.0 ng/ml), Dilution Buffer 
(=Blank), Quality Controls and samples, were pipetted into the appropriate wells. The 
plate was incubated at room temperature (ca. 25°C) for 1 hour, shaking at ca. 300 rpm 
on an orbital microplate shaker. The wells were washed 5-times with Wash Solution 
(0.35 mL per well). All liquid was aspirated from the wells. 100 μl of Biotin Labelled 
Anti-Myostatin Prodomain Antibody Solution was added into each well. The plate 
was incubated at room temperature (ca. 25°C) for 1 hour, shaking at ca. 300 rpm on 
an orbital microplate shaker. The wells were washed 5-times with Wash Solution 
(0.35 mL per well). 100 μl of Streptavidin-HRP Conjugate was added into each well. 
The plate was incubated at room temperature (ca. 25°C) for 30 minutes, shaking at 
ca. 300 rpm on an orbital microplate shaker. The wells were washed 5-times with 
Wash Solution (0.35 mL per well). 100 μl of Substrate Solution was added into each 
well. The plate was incubated at room temperature for 10 minutes. The colour 
development was stopped by adding 100 μl of Stop Solution into each well. The 
absorbance was determined by reading the plate at 450 nm.  
2.3.7 Cytokine measurements 
High sensitivity human cytokine multiplex immunoassay kit may be used for 
analyses of many cytokines in culture supernatants simultaneously. The medium from 
myotubes incubated with and without BFA were collected. 13 cytokines in the 
conditioned media were analysed by Luminex multiplex technology. The 
concentrations of the cytokines were measured and the total amounts of the cytokines 
in the media were estimated. The total amount of the cytokines from the well or flask 
were related to the total amount of protein in the cell lysate from the same well or 
flask (Table 1). The amount of protein in the cell lysate indicated the amount of cells 
remaining after washing and incubation in the well or flask. By relating the amount of 
cytokines to the amount of protein we adjusted for the eventual differences in 
myotube density in the different wells or flasks. The ratio of media volumes (mL) to 
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the growth area (cm2) were 0.11 mL/cm2 for the wells and 0.07 mL/cm2for the 
flasks. The wells had 1.6 times higher volume per cm2 than the flasks.The cytokines 
tested were IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12(p70), IL-13, IFNγ, 
GM-CSF and TNFα. The filter was pre-wet by pipetting 200 uL of 1X Wash Buffer 
into each well of the microtiter plate. The plate was sealed and put on a plate shaker 
for 10 minutes at room temperature. Wash Buffer was removed by vacuum. The bead 
bottle was sonicated for 30 seconds and vortexed for 1 minute. 25 uL of the mixed 
beads were added to each well. Liquid was removed from the wells by vacuum. 50 
uL Assay Buffer were added to the 0 Standard and the sample wells. 50 uL of each 
Standard and Control were added to appropriate wells. 50 uL matrix solution were 
added to the Background, Standards, and Control wells. The plate was covered with 
aluminium foil and incubated with agitation on a plate shaker overnight (19 hr). The 
fluid was removed by vacuum aspiration. The plate was washed with 200 uL Wash 
Buffer 2 times. The removing of Wash Buffer was performed by vacuum. 50 uL of 
Detection Antibody Coctail were added each well. The plate was sealed with 
aluminium foil, and incubated on a plate shaker for 1 hour at room temperature. 50 
uL Streptavidin-Phycoerythrin were added each well. The plate was covered with 
aluminium foil, and incubated with agitation on a shaker for 30 minutes at room 
temperature. The content was removed by vacuum. The plate was washed with 200 
uL Wash Buffer two times and the Wash Buffer was removed by vacuum. 100 uL of 
Sheat Fluid were added each well. The plate was covered with aluminium foil and 
resuspended the beads on plate shaker for 5 minutes. The plate was read on Luminex 
Instrument. 
2.3.8 Brefeldin A (BFA) and protein secretion 
The myotubes were added incubation medium with or without 1 ug/mL BFA. By 
comparing the amount of protein measured in the media from the two treatments we 
can explore the secretion of different peptides and proteins derived from myotubes. 
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2.3.9 SDS and two-dimensional electrophoresis 
Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) is a method for 
separating complex mixtures of proteins. The proteins are separated in two steps, first 
by their charge and then by their mass. After separation and staining, the spots are 
excised from the gel and digested using trypsin and the peptide fragments are 
characterized by MS. Proteins (17 ul) were separated according to their molecular 
weight in SDS-PAGE using NuPAGE 4-12 % Bis-Tris gels (Invitrogen). In two-
dimensional electrophoresis the proteins were first separated by isoelectric focusing 
using Immobiline DryStrip pH 3-10, 7 cm (GE Healthcare) which was rehydrated in 
7 M urea, 2 M thiourea, 4 % CHAPS, 0.2% Pharmalytes and 1.5 mg/ml DDT. The 
samples (10 ul) were added rehydration buffer (115 ul) and applied along the whole 
strip and rehydrated over night.  The focusing was run with a Bio-Rad Protein IEF 
Cell (Bio-Rad). After the focusing the strips were equilibrated in LDS sample buffer 
(Invitrogen) containing reducing and alkylating solutions and the proteins were 
applied to SDS-PAGE as described above.  Proteins were visualized by staining 
either  with Coomassie or silver.  Magic Mark protein standard (Invitrogen) was used 
to estimate molecular weights. The proteins from the gel were further characterized 
by Matrix-assisted laser desorption/ionization-time of flight mass spectrometer 
(MALDI-TOF). 
2.3.10 MALDI-TOF MS 
After isolation of proteins by gel electrophoresis, the unknown proteins can be 
identified by the use of MALDI-TOF MS. First the proteins are being digested with 
an enzyme and then the masses of the proteolytic peptides are being matched with a 
database. The biomolecules are ionized and then they are being accelerated in an 
electric field and go into a flight tube. In the tube the molecules are separated 
according to their mass to charge ratio and they come to the detector at different 
times, so that every molecule gives a special signal. 
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2.3.11 Experiment 1 – Lactate dehydrogenase (LDH)  activity in 
media from human myotubes at different stages of 
differentiation after incubation in serum-free medium for 6 or 
18 hours 
Human satellite cells were seeded and differentiated for 0, 2 and 5 days in three 12 
well plates as described above. On the day of the experiment the cells were being 
washed twice by adding and removing 1 mL preheated DMEM. The cells were added 
450 uL DMEM and incubated for 6 or 18 hours in 37° C in 5% CO2. The media was 
removed and centrifuged for 5 minutes by 3000 rpm. 400 uL supernatant was being 
frozen for later experiments. The wells were washed by adding and removing 1 mL 
PBS. The myotubes were lysed as described above. LDH in the supernatant was 
measured and related to the LDH measured in the cell lysis as described above. 
2.3.12 Experiment  2a – The effect of increasing the number of 
washing procedures on removal of radioactively labeled BSA 
from cultured human myotubes 
Human satellite cells were seeded and differentiated for 4 days  in three 12 well 
plates as described above. The wells were added 1 mL M3 with 0.01 uCi/mL 14C-
BSA and incubated for 24 hours in 37° C in 5% CO2. On the day of the experiment 
the radiolabelled media were transferred to vials, one pr well. The cells were being 
washed 1-12 times by adding and removing 1 mL preheated DMEM that was 
collected and transferred to vials, one pr well. The wells were added 1 mL serum-free 
medium and incubated for 24 hours in 37° C in 5% CO2. The media was removed 
and centrifuged for 5 minutes by 3000 rpm. The cells were lysed as described above. 
The radioactivity in the media and the lysates were measured using Wallac Microbeta 
Trilux. LDH in the supernatant was measured and related to the LDH measured in the 
cell lysis as described above. Proteins were measured as described above. 
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2.3.13 Experiment  2b – The effect of increasing the number of 
washing procedures on removal of radioactively labeled BSA 
from cultured human myotubes 
Human satellite cells were seeded and differentiated for 4 days in a 12 well plate as 
described above. 3 wells were used in the experiment. The wells were added 1 mL 
M3 with 0.086 uCi/ml (190000dpm/ml) 14C-BSA and incubated for 24 hours in 37° 
C in 5% CO2. On the day of the experiment the radiolabelled media were transferred 
to vials, one pr well. The wells were being washed 9 times by adding and removing 1 
mL preheated DMEM that was collected and transferred to vials, one pr well. The 
wells were added 1 mL serum-free medium and incubated for 24 hours in 37° C in 
5% CO2. The media was removed and centrifuged for 5 minutes by 3000 rpm. The 
cells were lysed as described above. The radioactivity in the media and the lysates 
were measured using Wallac Microbeta Trilux. LDH in the supernatant was measured 
and related to the LDH measured in the cell lysis as described above. Proteins were 
measured as described above.  
2.3.14 Experiment  3 – The effect of varying the number of 
repeated washing procedures on LDH activity in cultures of 
human myotubes 
Human satellite cells were seeded and differentiated for 4 days in a 12 well plate as 
described above. 9 of the wells were used. On the day of the experiment the cells 
were being washed 3, 6 or 9 times by adding and removing 1 mL preheated DMEM. 
The wells were added 500 uL DMEM and incubated for 24 hours in 37° C in 5% 
CO2. The media was removed and centrifuged for 5 minutes by 3000 rpm. The cells 
were lysed as described above. Proteins were measured on the lysates as described 
above. LDH in the supernatant was measured and related to the LDH measured in the 
cell lysis as described above.  
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2.3.15 Experiment 4 - Myostatin concentration in media from 
cultured human myotubes at different stages of differentiation 
after incubation in serum-free medium for 6 or 18 hours 
Myostatin was measured in frozen samples from experiment 2. Myostatin 
concentrations were measured using Human Myostatin ELISA as describedabove. 
2.3.16 Experiment 5 - IL-6 concentration in media from human 
myotubes at different stages of differentiation after incubation 
in serum-free medium for 6 or 18 hours  
IL-6 was measured in frozen samples from experiment 2. IL-6 concentrations were 
measured using ELISA as described above. 
2.3.17 Experiment 6 - IL-6 concentration in media from human 
myotubes after incubation in medium with and without the 
inhibitor Brefeldin A 
Human satellite cells were seeded and differentiated for  2 or 5 days  in four 12 well 
plates as described above. On the day of the experiment the cells were being washed 
six times by adding and removing 1 mL preheated DMEM. The wells were added 
400 uL DMEM or DMEM with Brefeldin A (5 ug/ml) and incubated for 0, 1, 2, 3, 4 
or 6 hours in 37° C in 5% CO2. The media was removed and centrifuged for 5 
minutes by 3000 rpm. The myotubes were lysed as described above. LDH in the 
supernatant was measured and related to the LDH measured in the cell lysis as 
described above. Proteins in the lysate was measured as described above. IL-6 in the 
supernatant was measured as described above.  
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2.3.18 Experiment 7 - IL-6 concentration in media from human 
myotubes after incubation in medium with increasing 
concentrations of Brefeldin A 
Human satellite cells were seeded and differentiated for 5 days in two 12 well plates 
as described above. On the day of the experiment the cells were being washed six 
times by adding and removing 1 mL preheated DMEM. The wells were added 400 uL 
DMEM with 0, 1, 2, 3, 4, or 5 ug/ml Brefeldin A and incubated for 6 hours in 37° C 
in 5% CO2. The media was removed and centrifuged for 5 minutes by 3000 rpm. The 
myotubes in one of the plates were lysed as described above. The myotubes in the 
second plate were being washed twice by adding and removing 1 mL preheated 
DMEM. The myotubes in the second plate were added 0,4 mL DMEM and incubated 
for 3 hours in 37° C in 5% CO2. The media was removed and centrifuged for 5 
minutes by 3000 rpm. The myotubes in the second the plate were lysed as described 
above. LDH in the supernatants was measured and related to the LDH measured in 
the cell lysis as described above. Proteins in the lysates was measured as described 
above. IL-6 in the supernatants was measured as described above. 
2.3.19 Experiment 8 - IL-6 concentration in media from human 
myotubes after incubation in serum-free medium for different 
periods of time 
Human satellite cells were seeded and differentiated for  5 days  in two 12 well plates 
as described above. On the day of the experiment the cells were being washed six 
times by adding and removing 1 mL preheated DMEM. The wells were added 400 uL 
DMEM and incubated for 0, 1, 3, 6, 9, 24, 48 or 72 hours in 37° C in 5% CO2. The 
media was removed and centrifuged for 5 minutes by 3000 rpm. The myotubes were 
lysed as described above. LDH in the supernatant was measured and related to the 
LDH measured in the cell lysis as described above. Proteins in the lysate was 
measured as described above. IL-6 in the supernatant was measured as described 
above. 
 29
2.3.20 Experiment 9 - Cytokine secretion in media from human 
myotubes after incubation in serum-free medium with or 
without Brefeldin A for 6 hours 
Human satellite cells from donor 29 were seeded and differentiated for 5 days  in two 
12 well plates as described above. Human satellite cells from donor 29, 30 and 37 
were seeded out in two 75 cm2 flasks each, as described above. On the day of the 
experiment the cells were being washed six times by adding and removing preheated 
DMEM, 1 mL in each well of the plates and 20 mL for the flasks. The cells were 
added DMEM or DMEM with Brefeldin A (1ug/ml), 0.4 mL in each well of the 
plates and 20 mL in each flask and incubated for 6 hours. The media was removed 
and centrifuged for 10 minutes by 4000 rpm. 3 and 3 wells were pooled (donor 29). 
Cytokines in the conditioned media from the flasks (donor 29, 30 and 37) were 
measured by Luminex multiplexing technology as described above. Samples from the 
plates (donor 29) and from the flasks (donor 30 and 37) were frozen at 20 ° C and 
sent to Hormonlaboratoriet at Aker University Hospital for proteomic analysis.  
2.3.21 Experiment 10 - Proteomic analysis on media from human 
myotubes after incubation in serum-free medium with or 
without Brefeldin A for 6 hours 
At Aker University Hospital: Centrifugation through membranes with a cut-off of 10 
kDa (Nanosep 10K OMEGA, Pall Corporation) was used to concentrate the proteins. 
The samples were concentrated from 2 mL to 60 ul, 100 ul, 50 uL and 100 uL for the 
samples from donor 29 with BFA, donor 29 without BFA, donor 37 with BFA and 
donor 37 without BFA, respectively. SDS-PAGE and 2-dimensional electrophoresis 
was performed as described above. 
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2.3.22 Experiment 11 - Proteomic analysis on media from human 
myotubes after preincubation in medium with high and low 
glucose and with and without Brefeldin A 
Human satellite cells were seeded and differentiated for 3 days in a 12 well plate as 
described above. The wells were added 400 uL M3 or M3 with 20 mM glucose and 
preincubated for 4 days in 37° C in 5% CO2, media changed after 2 days. On the day 
of the experiment the cells were being washed six times by adding and removing 1 
mL preheated DMEM. The wells were added 400 uL DMEM or DMEM with 
Brefeldin A (1 ug/ml) and incubated for 6 hours in 37° C in 5% CO2. The media 
were centrifuged for 40 minutes by 100 000 rpm in 10 ° C. The supernatants were 
frozen in 20 ° C and sent to Hormonlaboratoriet at Aker University Hospital for 
proteomic analysis.  At Aker University Hospital the samples were concentrated by 
centrifugation through a membrane with a cut-off of 10 kDa. 10 uL from each sample 
was added to the gel SDS-PAGE performed as described above. Western blot was 
performed with IL-6 antibody and an antibody towards a specific sugarmodification. 
1 mL sample was concentrated to 80 ul, 10 uL was mixed with SDS-applying buffer 
and 80 % applied to the gel. Western blot was performed with anti-albumin. 2-
dimensional gel electrophoresis with silverstain was performed. 
2.3.23 Experiment 12 - IL-6 concentration in media from human 
myotubes after incubation in medium with different fatty acids 
bound to BSA in different concentrations for 6 hours 
Human satellite cells were seeded and differentiated for 5 days in two 12 well plates 
as described above. On the day of the experiment the cells were being washed six 
times by adding and removing 1 mL preheated DMEM. The wells were added 400 uL 
DMEM with either palmitate, linoleate or eicosapentaenate in the concentrations 0, 
50, 100, 175, 250 or 500 uM, or BSA in concentrations 0, 20,40, 70, 100 or 200 uM 
and incubated for 6 hours in 37° C in 5% CO2. The media was removed and 
centrifuged for 5 minutes by 3000 rpm. The myotubes were lysed as described above. 
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LDH in the supernatant was measured and related to the LDH measured in the cell 
lysis as described above. Proteins in the lysate were measured as described above. IL-
6 in the supernatant was measured as described above. 
2.3.24 Experiment 13 - IL-6 concentration in media from cultured 
human myotubes after incubation in medium with different 
fatty acids dissolved in ethanol for 6 hours 
Human satellite cells were seeded and differentiated for 5 days in a 12 well plate as 
described above. On the day of the experiment the cells were being washed six times 
by adding and removing 1 mL preheated DMEM. The wells were added 400 uL 
DMEM with either palmitate, linoleate or eicosapentaenate solved in 0.5 % ethanol in 
the concentrations 1, 5 or 50 and incubated for 6 hours in 37° C in 5% CO2. The 
media was removed and centrifuged for 5 minutes by 3000 rpm. The myotubes were 
lysed as described above. LDH in the supernatant was measured and related to the 
LDH measured in the cell lysis as described above. Proteins in the lysate were 





3.1 Lactate dehydrogenase (LDH) activity in media from 
human myotubes at different stages of differentiation 
after incubation in serum-free medium for 6 or 18 hours 
To find out if the myotubes tolerated serum-free conditions over time we let them 
incubate in serum free medium for 6 and 18 hours (see Materials and Methods, 
Experiment 1). The enzymatical LDH activity was measured in the conditioned 
media as an indicator of plasma membrane integrity/cell survival and related to LDH 
activity measured in the lysate (100% cell death). The cells were tested at different 
stages of differentiation. 
 
Figure 1. LDH activity in media from myotubes incubated under serum-free conditions. 
Undifferentiated myoblasts and myotubes differentiated 2 or 5 days were incubated in serum-free 
medium for 6 or 18 hours. The bars show mean relative LDH activity ± SEM (n=5) measured in the 
conditioned media. 
After incubation for 6 and 18 hours the undifferentiated and 2-days differentiated 
cells showed a relative LDH-activity that was less than 10 % (Fig. 1). For the 5-days 
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differentiated cells the relative LDH-activity was 20 % after 6 hours incubation and 
66 % after 18 hours incubation (Fig. 1). For these cells the relative LDH-activity was 
thus 3 times higher after 18 hours compared to 6 hours. We observed that the LDH 
activity in the media increased with increasing myotube differentiation status for cells 
incubated in serum free medium, both after 6 and 18 hours (Fig. 1). Myoblasts and 
myotubes that had differentiated 2 days showed generally less LDH activity than the 
myotubes that had differentiated 5 days. There was more LDH activity in the media 
from 5-days differentiated cells that had incubated for 18 hours than for 6 hours. 
Assuming that serum-free medium would represent stress for the cells we expected an 
increase in LDH activity with increasing time in serum-free medium from 6 to 18 
hours independent of differentiation status. On background of these results we chose 
to incubate the cells for 6 hours.  
3.2 The effect of increasing the number of washing 
procedures on removal of radioactively labeled BSA 
from cultured human myotubes 
To investigate how many times we needed to wash the cells to remove an adequate 
amount of proteins from the growth-medium, 14C-BSA was used as a marker for 
macromolecules (see Materials and Methods, Experiment 2a). We made the 
assumption that the amount of 14C-BSA removed can be compared with the amount 
of the total of proteins removed. Hence, a known concentration of 14-C-BSA, which 
was quantified by scintillation counting, was added to the medium and 14-C-BSA 
removal was monitored. The myotubes were washed by adding and removing serum-
free medium to the culturing dish repeatedly. After removal, 14-C-BSA was 
estimated by scintillation counting in the wash solutions. 
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Figure 2. Level of radioactivity in rinsings of cultured human myotubes incubated with 
radolabeled BSA.  After 4 days of differentiation human myotubes were incubated with 14C-BSA 
and then washed 1-12 times. The diagram shows radioactivity, as a measure of 14C-BSA, in washing 
solutions 1-12 relative to the total in all washing solutions. The experiment was performed in 
triplicates and each point represents mean ± SEM. 
 
Amount of radioactivity decreases from 1st to 2nd (2) washing medium (Fig. 2). After 
the 2nd washing the media contain less than 0.1 % radioactive BSA of what was 
initially added (Fig. 2).  We conclude that there was too little radioactivity added to 
compare the small differences between the washes following the 2nd washing. 
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3.3 The effect of increasing the number of washing 
procedures on removal of radioactively labeled BSA 
from cultured human myotubes 
To further investigate the removal of BSA by washing we performed the same 
experiment as above, but this time with a higher total amount of 14-C-BSA (see 
Materials and Methods, Experiment 2b). 
 
Figure 3. Level of radioactivity in rinsings of cultured human myotubes incubated with 
radolabeled BSA. After 4 days of differentiation human myotubes were incubated with 14C-BSA 
and then washed 9 times. The diagram shows radioactivity, as a measure of 14C-BSA, in washing 
solutions 1-9 relative to the total in all washing solutions. The experiment was performed in 
triplicates and each point represents mean ± SEM.  
 
The 1st washing contained 1.5 % of total radioactive BSA (Fig. 3). The 2nd washing 
contained 0.1 % of total radioactive BSA (Fig. 3). Washing solution 3-9 contained 
less than 0.05 % of total radioactive BSA (Fig. 3). There was a gradual decrease in 
radioactive BSA in the washing solutions of the first 6 washing procedures (Fig. 2.2). 
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We conclude that it is necessary to wash the cells 6 times to remove an adequate 
amount of serum. 
3.4 The effect of varying the number of repeated washing 
procedures on LDH activity in cultures of human 
myotubes 
To investigate how many times we could wash the wells without harming the cells we 
used LDH-activity as a measurement of cell integrity (see Materials and Methods, 
Experiment 3). We suspected that the washings flushed away the cells and measured 
proteins in the lysate as an indication of how many cells there are left after the 
washings. We washed the myotubes by adding and removing serum-free medium 
(DMEM). 
 
Figure 4. The effect of the number of repeated washing procedures on LDH activity in cultured 
human myotubes. Human myotubes were washed by adding and removing washing solution 3, 6 or 
9 times and incubated in medium (DMEM) for 24 hours. The conditioned media were collected and 
the figure shows the LDH activity measured in the media related to the total LDH activity measured 
in lysed cells (relative LDH activity). The experiment was done once in triplicates and each point 
represents mean ± SEM.  
 37
 
Figure 5. Protein concentration in the lysate of the myotubes after exposure of different 
number of washings. The myotubes were washed 3, 6 and 9 times with washing solution and 
incubated for 24 hours. The bars represent protein concentration measured in total cell lysates (mean 
± SEM) of one experiment performed in triplicates. 
 
After 3, 6 and 9 washes the relative LDH-activity in the media is 6.6, 3.4 and 2.0 %, 
respectively. Increasing the number of washes from 3 to 9 reduced the LDH-activity 
significantly (P = 0.03). The protein concentrations measured in the lysates after 
exposure of 3, 6 and 9 washes were 68.0, 64.9 og 59.1 ug/mL, respectively. Lysates 
from myotubes exposed to 9 washes had statistically less protein content than  lysates 
from myotubes exposed to 3 washes (P = 0.037). 
The LDH activity decreased significantly from 3 to 9 washings as opposed to our 
expectations. We consider damage of the cells relatively small and the need to 
remove serum from the media necessary to a degree that the necessity to wash the 
cells many times exceeds the need to protect the cells. We suggest that the cells 
should be washed 6 times. 
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3.5 Myostatin concentration in media from cultured human 
myotubes at different stages of differentiation after 
incubation in serum-free medium for 6 or 18 hours 
Because we wanted to explore whether skeletal muscle cells released proteins we 
searched for myostatin, which is a protein known to be produced in skeletal muscle 
(see Materials and Methods, Experiment 4). Frozen supernatants from experiment 
1 were thawed and myostatin concentration was determined by ELISA.  
Probably the myostatin concentrations in the conditioned media from the myotubes 
were below the detection limit for our ELISA assay. 
3.6 IL-6 concentration in media from human myotubes at 
different stages of differentiation after incubation in 
serum-free medium for 6 or 18 hours 
We investigated whether different differentiation status affected the release of IL-6 
and whether the release of IL-6 increased with increasing time in serum free medium 
(see Materials and Methods, Experiment 5). Frozen supernatants from experiment 
1 were thawed and IL-6 concentration was determined by ELISA. 
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Figure 6. IL-6 concentration in the media from myotubes incubated without FCS.  IL-6 
concentration was measured in the media from muscle cells differentiated 0, 2 and 5 days and 
incubated in medium without serum for 6 or 18 hours. The bars show mean concentration of IL-6 and 
standard deviation for duplicates from each well (n = 2).  
 
The concentrations of IL-6 in the media of undifferentiated myoblasts were 0.13 
pg/mL and 0.45 pg/mL after 6 and 18 hours of incubation, respectively. 
Undifferentiated and 5-days differentiated myotubes had more than 3 and almost 2 
times, respectively, higher concentration of IL-6 in the media from 18 hours of 
incubation compared to 6 hours of incubation. The myotubes that had been 
differentiated for two days had 1.0 pg/mL IL-6 in the media after 6 hours of 
incubation. This was the highest in this experiment.  
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3.7 IL-6 concentration in media from human myotubes 
after incubation in medium with and without the 
inhibitor Brefeldin A 
To  investigate whether IL-6 was released as a result of secretion or leakage, we 
measured IL-6 concentration in media from myotubes following incubation for 6 
hours in medium containing the inhibitor Brefeldin A (see Materials and Methods, 
Experiment 6). 
 
Figure 7. IL-6 concentration in the supernatants in media from myotubes incubated with or 




Figure 8. Protein concentration in the lysates of myotubes after incubation with medium with 
or without BFA. The myotubes were incubated with 400 uL DMEM or DMEM with BFA (5 
ug/mL) for 0, 3 or 6 hours. The bars represent protein concentration measured in total cell lysates 
(mean ± SEM) of one experiment performed in triplicates. 
 
The IL-6 concentration in the media from cells incubated without BFA was higher 
than in the media from cells incubated with BFA. The IL-6 concentration in the 
media from all cells increased with increasing time.   
The lower concentration of IL-6 in the supernatants from myotubes incubated in 
media with BFA compared to the incubation in media without BFA suggests 
inhibition of active secretion by BFA. IL-6 was thus used as a marker for protein 
secretion, because we assumed that if BFA inhibited secretion of IL-6 it would most 
probably inhibit secretion of other proteins as well.  
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3.8 IL-6 concentration in media from human myotubes 
after incubation in medium with increasing 
concentrations of  Brefeldin A 
To explore how different concentrations of BFA would influence the concentration of 
IL-6 in the media we incubated the myotubes for 6 hours in media with increasing 
concentrations of BFA (see Materials and Methods, Experiment 7).  
 
Figure 9. IL-6 in media from myotubes incubated with increasing concentrations of BFA.  The 
five days differentiated myotubes were incubated in medium (DMEM) with 0, 1, 2, 3, 4,or 5 ug/mL 
BFA for 6 hours. IL-6 concentrations were measured in the supernatants. The bars show mean 
concentration ± SEM (n=4) of IL-6 in the media from two wells in duplicate. 
 
The IL-6 concentration was more than 3.5 pg/mL for the controls. The IL-6 
concentration is approximately 0.5 pg/mL for all the cells incubated in BFA, 
independent of BFA concentration. The lowest concentration of BFA (1 ug/mL) 
inhibited secretion of IL-6 by 87.5 %.  
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There was almost complete inhibition of secretion of IL-6 even with only 1 ug/ml 
BFA in the medium. Because even the smallest concentration of BFA seemed to give 
the inhibition that we needed we chose to use it. 
3.9 IL-6 concentration in media from human myotubes 
after incubation in serum-free medium for different 
periods of time 
To optimalize the chance of finding an appropriate amount of protein in the media we 
measured how increasing time would influence the release of IL-6 in the media (see 
Materials and Methods, Experiment 8). The myotubes were incubated in serum-
free medium for different periods of time varying from 0 to 72 hours. 
 
Figure 10. IL-6 concentration in media from myotubes incubated up to 72 hours in DMEM. 
The spots show mean ± SEM (n=6) concentrations of IL-6 in the media after the different incubation 




Figure 11. LDH activity in supernatants from myotubes  incubated up to 72 hours in DMEM.  
The five days differentiated human myotubes were incubated in medium (DMEM) for 9, 24, 48 or 72 
hours. The conditioned media were collected and the diagram shows the LDH activity measured in 
the media related to the total LDH activity measured in lysed cells (relative LDH activity). The 
experiment was done once with three wells in duplicates and each point represents mean ± SEM.  
 
There was an immediate release of IL-6. The curve was almost linear the first 6 
hours. There was a steep rise that flattened a little after 10 hours, but continued to rise 
although not so fast. The IL-6 concentration in the medium after 6 hours was 59.8 % 
of the concentration after 72 hours. The relative LDH-activity in the media from cells 
that had incubated in serum-free media for 9, 24, 48 and 72 hours were 1.5 %, 4 %, 
10 % and 8 %, respectively. The LDH-activity doubled from 24 hours incubation to 
48 hours incubation. Since we chose to measure IL-6 in our media for validation 
purposes we do not know whether other myokines may need longer or shorter time to 
be released and might need longer or shorter incubation time. The increasing LDH 




3.10 Cytokine secretion in media from human myotubes 
after incubation in serum-free medium with or without 
Brefeldin A for 6 hours 
To search for nouvel myokines we measured the following cytokines with 
multiplexing technology:  IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 
(p70), IL-13, IFNγ, GM-CSF, TNF-α (see Materials and Methods, Experiment 9). 
We seeded the cells in flasks to get more cells and possibly a larger amount of 
protein. The myotubes were incubated in medium with or without BFA for 6 hours 
before we analyzed the media. The concentrations of the suspected, secreted 
cytokines were measured and total amount of cytokines in the media was estimated. 
The total amount of cytokines from well or flask was related to total amount of 
protein in cell lysate from the same well or flask. The amount of protein in the cell 
lysate indicated the amount of cells left after washing and incubation. By relating the 
amount of cytokines to the amount of protein we adjusted for eventual differences  in 
myotube density in the different wells/flasks. The ratio media volume (mL) to growth 
area (cm2) was 0.11 mL/cm2 for the wells and 0.07 mL/cm2 for the flasks. The wells 
had 1.6 times volume pr cm2 as the flasks.  
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Table 1. The amount of cytokines in the media related to the amount of protein in the cell 
lysate from the well or flask (pg cytokine/mg protein) 
 Donor 29 Donor 30 Donor 37 
BFA - + - + - + 
IL-6 21.36± 0.96 1.29±0.08*** 2.65±0.25 0.41#±0.14** 200.56±12.18 2.87±0.11***
IL-8 100.22±2.60 2.64±0.30*** 4.31±.027 0.36±0.05*** 199.13±4.23 2.15±0.14***










IL-10 0.15#±0.08 0.25#±0.10 0.21#±0.09 0.42#±0.17 0.47#±0.07 0.16#±0.05 
GM-CSF 0.91#±0.13 0.63#±0.09 0.73#±0.13 0.42#±0.08 0.52#±0.05 0.33#±0.06 
TNFα ND ND ND ND ND ND 
IL-1β ND ND ND ND ND ND 
IFNγ ND ND ND ND ND ND 
IL-12 ND ND ND ND ND ND 
IL-2 ND ND ND ND ND ND 
IL-4 ND ND ND ND ND ND 
IL-5 ND ND ND ND ND ND 
The mean values ± SEM are based on triplicate measurements (except for donor 37 without 
BFA which are based on duplicates),  ND = not detectable, # extrapolated values, * < 0.05, **  
< 0.01, *** < 0.001 
 
 
IL-6, IL-8, IL-7 and IL-13 were detected. IL-6 and IL-8 had significant differences 
between the media with and the media without BFA. The medium from donor 29 had 
the highest concentration of IL-13 pr mg protein compared to the other donors. The 
mean IL-13 concentration in the medium without BFA from donor 29 was 10.5 
pg/mL and had more than 3.5 times higher concentration than the mean IL-13 
concentration in the medium with BFA.  
The concentration of IL-6 in the supernatant was 80.6 pg/mL. This means that the 
concentration from 2 mL to 100 uL resulted in the concentration 1.6 pg IL-6/ul.  
Media from hepatocytes and adipocytes  were tested with the same multiplex analysis 




3.11 Proteomic analysis on media from human myotubes 
after incubation in serum-free medium with or without 
Brefeldin A for 6 hours 
To get more proteins for the proteomic analysis we seeded the cells in flasks to get 
more cells and possibly a larger amount of protein (see Materials and Methods, 
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Figure 12. Two-dimensional electrophoresis of proteins from media of cultured human 
myotubes after incubation in serum-free medium with or without Brefeldin A for 6 hours. 
Differentiated myotubes were incubated in media without BFA (left panel) and media with BFA 
(right panel). The proteins from the conditioned media were first separated by isoelectric focusing 
and then by size. 
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Comparing the pictures we can see 9 spots more when the myotubes were incubated 
without BFA. The media from myotubes incubated without BFA contained high 
concentrations of protein compared to the media derived from myotubes incubated 
with BFA. The high protein concentrations lead to clotting of the filters when the 
concentration of the proteins took place. This resulted in a poorer concentration and a 
higher final volume with the same cut-off value for media derived from myotubes 
incubated without BFA. The proteins from media from myotubes from donor 29 and 
37 incubated with BFA were concentrated from 2 mL to 60 ul and 50 ul, respectively. 
For both donors incubated without BFA 2 mL media ended up with 100 ul. Because 
of no adjustment before the electrophoresis was performed, the gel pictures showed 
weaker differences between media from myotubes incubated with and without BFA 
than there really were. 
The gel picture show more spots for the media from myotubes incubated without 
BFA. This supports our earlier conclusion; that BFA inhibits secretion. 10 ul and 
estimated 16,1 pg IL-6 applied on the gel was enough to visually detect proteins with 
2-D PAGE, but not enough to further identify secretion products with MALDI-TOF. 
3.12 Proteomic analysis on media from human myotubes 
after preincubation in medium with high and low 
glucose and incubation with and without Brefeldin A 
To investigate whether nutrients would affect the release of proteins we incubated the 
myotubes with different glucose concentrations (see Materials and Methods, 
Experiment 11). The myotubes were preincubated in either 5 mM or 20 mM glucose 
for four days. They were then incubated for 6 hours with and without BFA. The 
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supernatants were frozen and sent to Aker University Hospital for proteomic analysis. 














Figure 13. Silverstain of proteins derived from media of human myotubes after incubation in 
medium with high and low glucose and with and without Brefeldin A. Det må sies at det er 1D 
gelelektroforese  Row 1 and 2 show molecules from myotubes incubated without BFA and row 3 and 
4 show molecules from myotubes incubated in BFA. Molecules in row 1 and 3 derive from control (5 
mM glucose) and row 2 and 4 derive from myotubes incubated in high glucose (20 mM). 
SDS-PAGE. Bands 1 (row 1) and band 2, 3 and 4 (row 2) all in the range around 60 
kDa, do not exist in the samples with the inhibitor BFA (row 3 and 4) and are 
probably secretion products. Compared to the control (row 1) we can se two more 
bands from myotubes incubated with high glucose (row 2) Band 1 is albumin, band 2, 
3 og 4 are probably sugar modified albumin (band 3 and 4 might be degrading 
products of modified albumin). Prealbumin exists theorethically in this secretome 
according to Bortoluzzi [19].  
2-D and Western with albumin-antibody were done with the high glucose sample, to 
explore whether it was albumin being detected with silverstain. Western blotting with 
the albumin antibody provides a positive signal in this area, but not as strong as with 
intact albumin. Thus, it is still unclear what the two bands below albumin represent. 
 50
3.13 IL-6 concentration in media from human myotubes 
after incubation with different fatty acids bound to BSA 
in different concentrations  for 6 hours  
To further investigate whether nutrients would affect the release of proteins we 
incubated the myotubes for 6 hours with different concentrations of fatty acids bound 
to albumin (see Materials and Methods, Experiment 12). The fatty acids used in 
the experiment were palmitic acid (PA), linoleic acid (LA) and eicosapentaenoic acid 
(EPA) in the concentrations as follows: 50, 100, 175, 250 and 500 uM. PA stimulates 
the IL-6 secretion in the concentrations 50 uM and 100 uM. LA and EPA has a 
negative effect on the IL-6 secretion. 
 
Figure 14. IL-6 in medium from myotubes incubated with increasing concentrations of 
different fatty acids.  The five days differentiated myotubes were incubated in medium (DMEM) 
with PA, LA or EPA in 0, 50, 100, 175, 250 or 500 uM for 6 hours. IL-6 concentrations were 
measured in the supernatants. The bars show mean concentration ± SEM  for the concentrations of 
IL-6 in the media from two wells in duplicate. 
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3.14 IL-6 concentration in media from cultured human 
myotubes after incubation in medium with different fatty 
acids dissolved in ethanol  for 6 hours  
To investigate whether the variation of IL-6 release in the last experiment was due to 
BSA in the media or whether it was an effect of the different concentrations of the 
fatty acids we dissolved the fatty acids in ethanol (see Materials and Methods, 
Experiment 13). Ethanol provides an alternative way to get the fatty acids into the 
cells without albumin. We used the same fatty acids as above but in the following 
concentrations: 1, 5 and 50 uM. PA has a negative effect on IL-6 secretion. LA and 
EPA stimulate the IL-6 secretion.  
 
 
Figure 15. IL-6 in media from myotubes incubated with increasing concentrations of different 
fatty acids dissolved in ethanol.  The five days differentiated myotubes were incubated in medium 
(DMEM) with PA, LA or EPA in concentrations 1, 5 or 50 uM for 6 hours. IL-6 concentrations were 
measured in the supernatants. The bars show mean concentration ± SEM  for the concentrations of 
IL-6 in the media from two wells in duplicate. 
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4. Discussion 
To study the in vitro secretion of myokines from human skeletal muscle cells, we had 
to use a model appropriate for our hypothesis. Examination of many different 
proteins and pathways in cultured muscle cells suggest, although some differences 
exist, that these cells contain much of the same proteins and signaling systems as 
mature muscle fibres [20]. Thus, this model of primary human skeletal muscle cells is 
a useful and physiological relevant model to use for the study of proteins secreted 
from human muscle tissue, although contractions are not present.  
The medium routinely given cultured human myotubes contains abundant amounts of 
exogenous serum-derived proteins that had to be removed before analysis of myokine 
secretion could be performed. For the purpose of proteomics, we needed to generate 
conditioned media containing proteins derived from myotubes alone, without foetal 
calf serum (FCS) proteins (mainly bovine serum albumin (BSA)). Earlier 
experiments (personal communication, Dr. Vigdis Aas and colleagues at University 
of Oslo) indicated that it was important to remove as much protein from serum in the 
media as possible before the proteomics analysis. Thus, to find potential secretory 
proteins derived from myotubes in the medium, albumin and other proteins from the 
serum in the medium had to be removed before the samples could be analyzed by 2-
dimensional (2D)-gel electrophoresis.  
We had to incubate the myotubes in protein-free conditions to avoid contamination of 
proteins derived from FCS during proteomic analysis. Therefore we had to examine 
how the myotubes were influenced by serum free conditions. We wanted to maintain 
cell integrity and make sure we could reach detectable levels of secretory proteins in 
the conditioned medium. When assessing how long time the myotubes could be 
incubated without FCS, we explored the relative LDH activity (see below), and found 
that it was a 3 times higher relative LDH activity for 5 days differentiated myotubes 
incubated 18 hours compared to 6 hours. Thus, we chose to incubate the cells for 6 
hours.  
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When changing from media with to media without FCS, the serum proteins needed to 
be properly removed by washing the cells. Extensive washing can be harmful to the 
cells, but it was also important to evaluate the washing procedure with respect to the 
removal of exogenous proteins. Therefore, the aim was to find the number of wash-
cycles that sufficiently removed the albumin without significantly reducing cell 
viability.  
Two experiments using 14C-labelled BSA were performed to estimate the amount of 
protein removed by the washes. The conclusion was that the more we washed the 
cells, the more proteins were removed. After 6 washes we did not detect any 
differences and we conclude that it is necessary to wash the cells 6 times to remove 
an adequate amount of serum. 
In our search for new secretory proteins from myotubes it was important to monitor 
what condition the cells were in. In vitro culturing is closely associated with cell-
death and damaged or dead myotubes might contaminate the conditioned media with 
intracellular proteins and thus masque the secreted proteins [21]. To explore how 
washing influenced plasma membrane integrity, we measured LDH activity in the 
media. LDH is an intracellular enzyme which may leak out of the cell when the 
membrane is damaged. The principle of measuring LDH activity of cellular culture 
supernatants as a measure of cytotoxicity have successfully been applied on different 
cell types. LDH release assays are an appropriate and possibly preferable means of 
measuring cellular cytotoxic reactions  [22]. The LDH activity decreased 
significantly from 3 to 9 washings as opposed to our expectations. Because LDH 
activity was expected to rise with increasing number of washes we measured an 
additional variable to see if cells had been lost during the washing procedures. Protein 
content in cell lysates can be used as an indicator of the amount of cells. Therefore, 
we compared the amount of total cellular proteins in cells after different washing 
exposure. Our hypothesis was that the cells are being flushed away during washing. 
The decrease in protein concentration from 3 to 9 washings supports this theory. 
Another hypothesis is that some cells are more fragile, leak more LDH and are more 
easily washed away. If so the LDH activity will necessarily decrease together with 
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the protein concentration. A third hypothesis is that the washing flushed away fragile 
cells, and the cells that were left were robust and did not leak that much LDH. We 
suggest that the cells should be washed 6 times since the cells seemed to handle it 
well. In a previous study of myotubes, the cells were washed 4 times [23].  
It was also necessary to investigate how many days the cells should be differentiated 
before experiments were performed. When mononuclear myoblasts fuse to make 
multinuclear myotubes the muscle specific gene expression changes [24].To find out 
whether differentiation from myoblast to myotube has any effect on the myokine 
synthesis we let the cells differentiate from two to five days.  We considered it likely 
that differentiated cells, as being more developed, have also developed their abilities 
to release myokines.   
Before we began our search for novel myokines, we validated our muscle model 
system with regards to the secretion of known myokines. Myostatin is synthesized by 
skeletal muscle, circulates in the blood and functions as a negative regulator of 
muscle growth. There is increasing evidence that myoblasts and satellite cells are 
targets of myostatin signaling in vivo, although it is possible that also other cells can 
respond to myostatin. Overexpression of myostatin in mice have been shown to give 
a dramatic wasting syndrome (cachexia), characterized by loss of muscle and adipose 
tissue. This indicates that myostatin also has an effect on adipocytes [25]. Because of 
this, myostatin is regarded as a bona fide myokine and we wanted to explore this in 
our model system. We tried to measure myostatin but we could not trace any 
myostatin in the media from the myotubes with our methods. This tells us that our 
cells secrete myostatin in too small amounts to be detectable with our assay. Few 
commercial assays are available for measuring myostatin. Thus, instead of 
elaborating on this we chose to focus on a different myokine to validate our muscle 
model system. We chose to validate our cell model with respect to myokine secretion 
by measuring IL-6, a previously identified myokine. The aim was to examine if IL-6 
could be found in media of our cultured myoblasts and myotubes. Therefore, we 
performed an experiment to explore whether we could trace IL-6 in the media from 
the myotubes at all. We detected IL-6 in the media from both myoblasts and 
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myotubes. The myotubes that had been differentiated for 2 days had 1.0 pg/mL IL-6 
in the media after 6 hours of incubation. This was the highest result in this 
experiment. 
We also wanted to explore whether the proteins released from the myotubes into the 
media were due to secretion per se or just a secondary effect of cell damage. 
Brefeldin A (BFA) is a reversible inhibitor affecting intracellular protein transport 
[26]. It is a lactone antibiotic produced by fungal organisms, and BFA interferes 
specifically and reversibly with protein transport from endoplasmatic reticulum to 
Golgi apparatus and leads to accumulation of proteins inside endoplasmatic reticulum 
(ER) [27]. In mammalian cells BFA inhibits activation of a GTPase which is involved 
in formation of transport vesicles by recruiting coat proteins to intracellular 
membranes [28]. Thus, cells incubated with BFA might be used as a negative control 
to investigate whether release of proteins from myotubes was due to leakage or 
secretion. The lower concentration of IL-6 in the supernatants from myotubes 
incubated in media with BFA compared to the incubation in media without BFA 
suggests inhibition of active secretion by BFA. We started out giving the cells 5 
ug/mL BFA, but assuming that it was damaging for the cells to be incubated in high 
BFA concentrations, we explored whether the inhibition was complete also with 
lower concentrations of BFA. Our experiment showed that there was almost complete 
inhibition of secretion of IL-6 with only 1 ug/mL BFA in the medium. Because the 
lowest concentration of BFA tested seemed to give the inhibition that we needed, we 
chose to use 1 ug/mL in later experiments. 
Because the concentration of peptides and proteins in the media could be low and 
difficult to measure, we performed a time-course experiment of the IL-6 
concentration in the media, to explore how long the increase was linear. 
The IL-6 concentration in the media seemed to increase almost linearly up to 6 hours. 
The LDH-activity doubled from 24 hours incubation to 48 hours incubation. Other 
proteins might display different release patterns than IL-6, but as a trade-off between 
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myokine concentration and cell integrity we decided to incubate the myotubes for 6 
hours, also when searching for novel myokines. 
We then started our search for novel myokines using the model that we developed 
and validated. IL-6 is a known myokine [5]. Skeletal muscle cell cultures express 
several cytokines, such as IL-6, IL-8, interferon- γ (IFN-γ)  and tumor necrosis factor- 
α (TNF-α)  [29, 30]. Wanting to detect other known cytokines in the media from the 
myotubes, we tested 13 different cytokines by Luminex multiplexing technology. IL-
6, IL-8, interleukin-7 (IL-7) and interleukin-13 (IL-13) were detectable with our 
assay. IL-8 is, as mentioned in the Introduction, classified as a potential myokine [4]. 
We observed that the concentration of IL-13 decreased after incubation in BFA, 
which indicates that the release might be due to a secretion. 
Experiments have been performed searching for interleukin-1α (IL-1α), interleukin-4 
(IL-4), interleukin-10 (IL-10), interleukin-12 (IL-12) and IFN-γ [31]. Under all test 
conditions  none were found from human myoblasts.  
We sent samples to Hormonlaboratoriet at Aker University Hospital for proteomic 
analysis. Our ambition was to be able to “rediscover” IL-6 as a myokine. 
Theoretically, based on quantification by ELISA, the amount of IL-6 applied on the 
gel was enough to visually detect proteins with 2-D PAGE and silver staining. 
However, silver staining is not well compatible with further identifying secretion 
products with MALDI-TOF. We would need approximately 300 pg IL-6 protein to be 
able to characterize it further with MALDI-TOF. Therefore, we estimated that we 
would need 20 times more protein than in our experiments in order to “rediscover” 
IL-6.  
Circulating IL-6, insulin and free fatty acid concentrations have been associated with 
impaired insulin action in obese and type 2 diabetic individuals. Skeletal muscle 
represents a target of impaired insulin action. Studies under several metabolically 
different conditions have shown that cultured myotubes are responsive to fatty acids 
as well as glucose [10]. We measured IL-6 as a representative myokine to see 
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whether free fatty acids (FFAs) and glucose could affect IL-6 expression in human 
myotubes.  
First we performed one experiment where we let the myotubes incubate in medium 
containing different concentrations of glucose. We expected higher concentration of 
IL-6 in media from myotubes  incubated with low glucose concentration than high, 
because previous work indicate that IL-6 is released from myotubes and that the 
release is enhanced by low glycogen stores [32]. We did not detect any IL-6 at all.  
We performed one experiment where the myotubes were incubated in media 
containing fatty acids bound to BSA. Whereas palmitic acid (PA) seemed to stimulate 
the release of IL-6, we observed an inhibition of IL-6 release when the myotubes had 
been incubated with linoleic acid (LA) and eicosapentaenic acid (EPA) in different 
concentrations. Earlier experiments showed a significant increase in IL-6 production 
after incubation with PA. Unsaturated FFA did not activate IL-6 expression, whereas 
oleate reduced the secretion [9, 10].  
Experiments have also shown a small, but significant effect of free fatty acid-free 
BSA alone on IL-6 gene expression [10]. 
Because of this finding we performed one experiment where the fatty acids were 
solved in ethanol instead of bound to BSA. We then observed an inhibition of IL-6 
release when the myotubes were incubated in PA, and an increase of IL-6 
concentration when the myotubes were incubated in LA and EPA.  





We conclude from our studies that in the search for novel myokines, human 
myotubes in culture should be washed 6 times prior to incubation to remove proteins 
from the serum added to the media. The incubation period in serum free medium 
should be 6 hours, this seemed to suffice to give the cells time to release proteins into 
the media, while the cells are still in good condition. Based on our studies, 5 days of 
differentiation should ensure an optimal developmental stage for the cells to be able 
to secrete muscle proteins. In addition to IL-6 we detected some potentially new 
myokines; IL-7, IL-8 and IL-13. Our studies support the theory that myotubes release 
proteins with hormonal functions, and that the release might be influenced by energy 
carrying metabolites. Further studies are required to explore the role muscle tissue 
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